Michael R. Migden

7.9k total citations · 1 hit paper
107 papers, 3.2k citations indexed

About

Michael R. Migden is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, Michael R. Migden has authored 107 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Epidemiology, 50 papers in Oncology and 47 papers in Molecular Biology. Recurrent topics in Michael R. Migden's work include Nonmelanoma Skin Cancer Studies (59 papers), Hedgehog Signaling Pathway Studies (43 papers) and CAR-T cell therapy research (25 papers). Michael R. Migden is often cited by papers focused on Nonmelanoma Skin Cancer Studies (59 papers), Hedgehog Signaling Pathway Studies (43 papers) and CAR-T cell therapy research (25 papers). Michael R. Migden collaborates with scholars based in United States, Australia and Germany. Michael R. Migden's co-authors include Luc Dirix, Anne Lynn S. Chang, Karl D. Lewis, Aleksandar Sekulić, Axel Hauschild, Charles M. Rudin, Sirunya Silapunt, James Solomon, Simon Yoo and Robert L. Yauch and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael R. Migden

99 papers receiving 3.1k citations

Hit Papers

Efficacy and Safety of Vismodegib in Advanced Basal-Cell ... 2012 2026 2016 2021 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
    2012 1.0k citations Aleksandar Sekulić, Michael R. Migden et al. profile →

Peers

Michael R. Migden
Caterina Catricalà Italy
James Solomon United States
Rafael Botella‐Estrada Spain
Pablo L. Ortiz‐Romero Spain
Carlo Cota Italy
Mi Ryung Roh South Korea
Sumaira Z. Aasi United States
Emily Y. Chu United States
Marko Lens United Kingdom
Priyadharsini Nagarajan United States
Caterina Catricalà Italy
Michael R. Migden
Citations per year, relative to Michael R. Migden Michael R. Migden (= 1×) peers Caterina Catricalà

Countries citing papers authored by Michael R. Migden

Since Specialization
Citations

This map shows the geographic impact of Michael R. Migden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Migden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Migden more than expected).

Fields of papers citing papers by Michael R. Migden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Migden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Migden. The network helps show where Michael R. Migden may publish in the future.

Co-authorship network of co-authors of Michael R. Migden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Migden. A scholar is included among the top collaborators of Michael R. Migden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Migden. Michael R. Migden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Migden, Michael R., et al.. (2024). How We Do It: A Systematic Approach to Reapproximating the Terminal Medial Brow During Forehead Flap Reconstruction. Dermatologic Surgery. 51(3). 333–335.
2.
Migden, Michael R., et al.. (2023). Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review. Cancers. 15(12). 3094–3094. 15 indexed citations
3.
Na’ara, Shorook, Frederico O. Gleber‐Netto, Tongxin Xie, et al.. (2023). Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precision Oncology. 7(7). e2200490–e2200490. 9 indexed citations
4.
Migden, Michael R., Wanxing Chai‐Ho, Gregory A. Daniels, et al.. (2023). 777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS). SHILAP Revista de lepidopterología. A874–A874. 1 indexed citations
5.
Chen, Olivia, et al.. (2022). Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers. 14(15). 3653–3653. 27 indexed citations
6.
Rabinowits, Guilherme, Michael R. Migden, Todd Schlesinger, et al.. (2021). Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 1(4). 100045–100045. 9 indexed citations
7.
Patel, Jigar, et al.. (2021). Treatment of Advanced Cutaneous Squamous Cell Carcinoma: A Mohs Surgery and Dermatologic Oncology Perspective. Future Oncology. 17(35). 4971–4982. 6 indexed citations
8.
9.
Migden, Michael R., Danny Rischin, Stacie Hudgens, et al.. (2020). 1087P Time to clinically meaningful changes in pain in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab in a phase II clinical trial. Annals of Oncology. 31. S738–S738. 1 indexed citations
10.
11.
Migden, Michael R., et al.. (2018). A Nodular Hidradenoma of Atypical Location in Pregnancy. Acta Dermato Venereologica. 98(9). 908–909. 3 indexed citations
12.
Lear, John T., Michael R. Migden, Karl D. Lewis, et al.. (2017). Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. Journal of the European Academy of Dermatology and Venereology. 32(3). 372–381. 137 indexed citations
13.
Chen, Leon, et al.. (2017). Treatment of Advanced Basal Cell Carcinoma with Sonidegib: Perspective from the 30-Month Update of the BOLT Trial. Future Oncology. 14(6). 515–525. 23 indexed citations
14.
Migden, Michael R., Anne Lynn S. Chang, Luc Dirix, Alexander Stratigos, & John T. Lear. (2017). Emerging trends in the treatment of advanced basal cell carcinoma. Cancer Treatment Reviews. 64. 1–10. 65 indexed citations
15.
Migden, Michael R., et al.. (2017). Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014. Journal of the American Academy of Dermatology. 77(1). 55–62.e3. 5 indexed citations
16.
Lear, John T., Ralf Gutzmer, Michael R. Migden, et al.. (2016). Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis. Melanoma Research. 1 indexed citations
17.
Chang, Anne Lynn S., Karl D. Lewis, Sarah T. Arron, et al.. (2016). Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. Oncotarget. 7(46). 76118–76124. 17 indexed citations
18.
Sekulić, Aleksandar, Michael R. Migden, Karl D. Lewis, et al.. (2015). Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. Journal of the American Academy of Dermatology. 72(6). 1021–1026.e8. 154 indexed citations
19.
Sharpe, Hayley J., Grégoire Pau, Gerrit J.P. Dijkgraaf, et al.. (2015). Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma. Cancer Cell. 27(3). 327–341. 296 indexed citations
20.
Cowl, Clayton T., Udaya B. S. Prakash, P. Shawn Mitchell, & Michael R. Migden. (2000). Varicella-Zoster Virus Detection by Polymerase Chain Reaction Using Bronchoalveolar Lavage Specimens. American Journal of Respiratory and Critical Care Medicine. 162(2). 753–754. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Catricalà Breakdown of academic impact, for papers by James Solomon Breakdown of academic impact, for papers by Rafael Botella‐Estrada Breakdown of academic impact, for papers by Pablo L. Ortiz‐Romero Breakdown of academic impact, for papers by Carlo Cota Breakdown of academic impact, for papers by Mi Ryung Roh Breakdown of academic impact, for papers by Sumaira Z. Aasi Breakdown of academic impact, for papers by Emily Y. Chu Breakdown of academic impact, for papers by Marko Lens Breakdown of academic impact, for papers by Priyadharsini Nagarajan
Rankless by CCL
2026